Weigh the benefits of treatment against the increase in the risk of falls when using antidepressant therapy in the elderly

N. Van Der Velde, W. Meerding, C. Looman, P. Kannus, H. Sievnen, M. Palvanen, A. Darowski, S. Chambers, D. Chambers, P. Thapa, P. Gideon, T. Cost, R. Hubbard, P. Farrington, C. Smith, P. Vestergaard, L. Rejnmark, L. Mosekilde, W. Ray, M. GriffinE. Malcolm, S. Goldman, K. Stone, S. Ancoli-Israel, R. Asplund, S. Henriksson, S. Johansson, R. Asplund, S. Johansson, S. Henriksson, K. Ensrud, T. Blackwell, S. Ancoli-Israel, J. Teo, N. Briffa, A. Devine, A. Mayers, D. Baldwin, X. Li, R. Hamdy, W. Sandborn, D. Fairweather, J. Kerr, D. Harrison, B. Takkouche, A. Montes-Martnez, S. Gill, E. Haney, B. Chan, S. Diem

Research output: Journal PublicationShort surveypeer-review

Abstract

The risk of falls increases in elderly patients receiving treatment with antidepressants. The increased risk is probably attributable to the adverse effects (e.g. sedation, sleep disturbances and subsequent daytime drowsiness, balance problems, orthostatic hypotension and cardiac rhythm disorders) associated with antidepressants.

Original languageEnglish
Pages (from-to)23-26
Number of pages4
JournalDrugs and Therapy Perspectives
Volume26
Issue number2
DOIs
Publication statusPublished - 2010
Externally publishedYes

Keywords

  • Adrenergic-receptor-antagonists
  • Adverse reactions
  • Antidepressants
  • Elderly
  • Insomnia
  • Monoamine-oxidase-inhibitors
  • Orthostatic-hypotension
  • Sedation
  • Serotonin-uptake-inhibitors

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Weigh the benefits of treatment against the increase in the risk of falls when using antidepressant therapy in the elderly'. Together they form a unique fingerprint.

Cite this